Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study. [electronic resource]
Producer: 20000706Description: 428-33 p. digitalISSN:- 0003-4967
- Adult
- Aged
- Anti-Inflammatory Agents, Non-Steroidal -- therapeutic use
- Antibodies, Monoclonal -- administration & dosage
- Arthritis, Psoriatic -- drug therapy
- Drug Therapy, Combination
- Evaluation Studies as Topic
- Female
- Glucocorticoids -- therapeutic use
- Humans
- Infliximab
- Male
- Middle Aged
- Patient Selection
- Pilot Projects
- Prednisolone -- therapeutic use
- Psoriasis -- drug therapy
- Spondylitis -- drug therapy
- Spondylitis, Ankylosing -- drug therapy
- Statistics, Nonparametric
- Treatment Outcome
- Tumor Necrosis Factor-alpha -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.